semaglutide vs tirzepatide cardiovascular vs. for Weight Loss Know the Differences Between Semaglutide

Decide where you will inject the GLP-1

[4] Wegovy is administered as a once-weekly subcutaneous injection, with dosing gradually increased over 16-20 weeks (starting at 0.25 mg and increasing monthly to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg) to minimise gastrointestinal side effects

Ongoing monitoring Regular follow-up appointments allow your provider to track progress, adjust dosing, manage any side effects, and provide accountability and support

GLP-1 injections work in several key ways : Blood sugar regulation : They help the pancreas release insulin when blood sugar levels rise, keeping glucose levels steady

Es importante adems conocer el tipo de anlogo que recibe nuestro paciente, la semaglutida tiene una vida media larga por lo cual se administra semanalmente, mientras que la liraglutida tiene una vida media corta y debe administrarse a diario

A lower dose of 0.25 - 1.0 mg is used for diabetes management